Indeed, animals with dry eye receiving CCR2 antagonist presented a decrease in corneal alterations and in pro-inflammatory cytokines TNF-α and IL-1β on the ocular surface, confirming the importance of CCL2 in the pathology. The gene discussed is CCR2; the disease is dry eye syndrome.